Mao Jialin, Ansari Sameer A, Siddiqui Adnan H, Sedrakyan Art, Marinac-Dabic Danica, Sheldon Murray, Claffey Mairsíl, Hall Alicia M, Sancheti Harsh, Kim Thomas, Nguyen Nam, Liebeskind David S
Population Health Sciences, Weill Cornell Medical College, New York, New York, USA
Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
J Neurointerv Surg. 2025 Jan 25. doi: 10.1136/jnis-2024-021741.
Real-world data can be helpful in evaluating endovascular therapy (EVT) in ischemic stroke care. We conducted a pilot study to aggregate data on basilar artery occlusion (BAO) EVT from existing registries in the USA. We evaluated the availability, completeness, quality, and consistency of common data elements (CDEs) across data sources.
We harmonized patient-level data from five registry data sources and assessed the availability, completeness (defined by the presence in at least four data sources), and consistency of CDEs. We assessed data quality based on seven pre-defined critical domains for BAO EVT investigation: baseline patient and disease characteristics; time metrics; description of intervention; adjunctive devices, revascularization scores, complications; post-intervention National Institutes of Health Stroke Scale scores; discharge disposition; 30-day and 90-day mortality and modified Rankin Scale (mRS) scores.
The aggregated dataset of five registries included 493 BAO procedures between January 2013 and January 2020. In total, 88 CDEs were screened and 35 (40%) elements were considered prevalent. Of these 35 CDEs, the majority were collected for >80% of cases when aggregated. All seven pre-defined domains for BAO device investigation could be fulfilled with harmonized data elements. Most data elements were collected with consistent or compatible definitions across registries. The main challenge was the collection of 90-day outcomes.
This pilot shows the feasibility of aggregating and harmonizing critical CDEs across registries to create a Coordinated Registry Network (CRN). The CRN with partnerships between multiple registries and stakeholders could help improve the breadth and/or depth of real-world data to help answer relevant questions and support clinical and regulatory decisions.
真实世界数据有助于评估缺血性卒中治疗中的血管内治疗(EVT)。我们开展了一项试点研究,汇总美国现有登记处关于基底动脉闭塞(BAO)的血管内治疗数据。我们评估了各数据源中通用数据元素(CDE)的可用性、完整性、质量和一致性。
我们整合了来自五个登记处数据源的患者层面数据,并评估了CDE的可用性、完整性(定义为至少在四个数据源中存在)和一致性。我们基于BAO血管内治疗调查的七个预定义关键领域评估数据质量:基线患者和疾病特征;时间指标;干预描述;辅助设备、血管再通评分、并发症;干预后美国国立卫生研究院卒中量表评分;出院处置;30天和90天死亡率及改良Rankin量表(mRS)评分。
五个登记处的汇总数据集包括2013年1月至2020年1月期间的493例BAO手术。总共筛选了88个CDE,其中35个(40%)元素被认为是普遍存在的。在这35个CDE中,大多数在汇总时收集了超过80%的病例。BAO设备调查的所有七个预定义领域都可以通过统一的数据元素来实现。大多数数据元素在各登记处的收集定义一致或兼容。主要挑战是90天结局的收集。
该试点表明了跨登记处汇总和统一关键CDE以创建协调登记网络(CRN)的可行性。多个登记处和利益相关者之间建立伙伴关系的CRN有助于提高真实世界数据的广度和/或深度,以帮助回答相关问题并支持临床和监管决策。